🇺🇸 FDA
Patent

US 8569253

Methods and compositions for gene inactivation

granted A61KA61K2035/124A61K2239/31

Quick answer

US patent 8569253 (Methods and compositions for gene inactivation) held by Sangamo Biosciences, Inc. expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2035/124, A61K2239/31, A61K2239/38, A61K35/12